PRO/AH/EDR> Antibiotic Resistance – Europe: (salm, campyl, E. coli, MRSA) ECDC, EFSA, 2017

MRSA, Antimicrobial resistance — Worldwide/Unknown
An analysis of human isolates from 19 EU nations, plus Iceland and Norway, found that 57.7% of _Campylobacter jejuni_ — the commonest _Campylobacter_ species identified — were resistant to ciprofloxacin, and 45.4% were resistant to tetracyclines. Resistance to erythromycin was low (2%).
In Cyprus, Portugal, Spain, Lithuania, and Estonia, resistance to ciprofloxacin was from 80% to 96.5%. In addition, 8 of 17 countries saw a statistically significant increase in ciprofloxacin resistance